Jerry A. Mansfield Interview

Introduction. Extent and financial expenses for the delivery of health care in hospitals are planned within the framework of the annual approval of the Program of state guarantees of the free public delivery of health care (PSG), as well as of Territorial programs of state guarantees of the free public delivery of health care (TPSG). The research purpose is to carry out the comparative analysis of norms of extent and financial expenses for the unit of delivery of health care in hospitals, established at the federal and regional levels within the frameworks of PSG and TPSG in 2015. Materials and methods. Comparative analysis of norms of the delivery of health care in hospitals (norms of extent and financial expenses per extent unit), established by PSG and TPSG for 2015. The above regional norms have been analyzed in eight entities of the Russian Federation (Моscow, Saint-Petersburg, Stavropol region, Novosibirsk region, Khabarovsk region, Sverdlovsk region, Volgograd region, Nizhny Novgorod region), representing eight federal districts of the Russian Federation. Results. PSG and TPSG annually undergo changes, including those related to norms of the delivery of health care and extent of financial expenses, including the segment of hospital health care. During the last years, not only values of such indices have changed (reduction of norms of extent, as well as the growth of norms of financial expenditures per extent unit in hospital conditions), but also its measurement units (transition from bed days to hospitalization cases). The extent norm, established by PSG in 2015, was 0,193 case per one resident and 0,172 case per one insurant per year; the norm of financial expenses was 63 743,8 rubles and 22 233,1 rubles per one case of hospitalization at the expense of budgetary funds and of funds of the compulsory health insurance system accordingly. Entities of the Russian Federation establish, within TPSG frame works, norms of extent and financial expenses for the delivery of health care in hospitals. Actually, the values of such indices can differ from norms, established at the federal level. In this connection, the budgetary part of norm, not like the compulsory health insurance segment, can considerably differ from federal norms as to extent of health care and financial expenditures. Тhe territorial financial norm of the hospitalization case at the expense of compulsory health insurance funds was not lower than the federal norm in any of the analyzed entities of the Russian Federation.

This paper deals with the some of the important variable factors relating to health care in Saudi Arabia, with special emphasis on primary health. Other aspects considered are the financial influen...

Financial Toxicity: A Barrier to Achieving Health Equity in Cancer Care

As value-based care gains traction in response to towering health care expenditures and issues of health care inequity, hospital capacity, and labor shortages, it is important to consider how a value-based approach can be achieved in plastic surgery. Value is defined as outcomes divided by costs across entire cycles of care. Drawing on previous studies and policies, this article identifies key opportunities in plastic surgery to move the levers of costs and outcomes to deliver higher value care. Specifically, outcomes in plastic surgery should include conventional measures of complication rates and patient-reported outcome measures to drive quality improvement and benchmark payments. Meanwhile, cost reduction in plastic surgery can be achieved through value-based payment reform, efficient workflows, evidence-based and cost-conscious selection of medical devices, and greater use of outpatient surgical facilities. Lastly, the authors discuss how the diminished presence of third-party payers in aesthetic surgery exemplifies the cost-conscious and patient-centered nature of value-based plastic surgery. To lead in future health policy and care delivery reform, plastic surgeons should strive for high-value care, remain open to new ways of care delivery, and understand how plastic surgery fits into overall health care delivery.

definitive overview of health technology assessment in the U.S. and Europe, the biotech industry, adoption and use of medtech in health care.---The World Future Society, Best Books and ReportsThis excellent book provides a broad overview of the development, impact, and evaluation of health technology in the United States. . . .The authors take a well-organized and thorough approach to address these topics, combining reviews of each with case examples of particular technologies. . . .Given the broad scope of the book, it could serve as a text for students, an introduction to the field for healthcare professionals, or a tool for academics and policymakers wishing to fill knowledge gaps outside their disciplines. . . .The book makes a compelling case for the logic and potential benefits of medical technology evaluation as a tool for improving health care.---Journal of the American Medical Association By being comprehensive in their review, the authors chart a clear path to understanding the future of health care technology in America. They clarify the technical methods for evaluation and provide insight into the sociopolitical aspects of development and diffusion. Case studies are informative. Excellent reading for students and health professionals either as a textbook or as an off-the-shelf guide to methods for deciding among alternative technologies.---Norman W. Weissman, University of Alabama Technology today dominates every aspect of health care. This useful book offers a diverse range of perspectives for students, professors, and medical practitioners who wish to understand how to evaluate medical technology.---Joel Howell, University of Michigan Medical School Technology in American Health Care is a comprehensive, multidisciplinary guide to understanding how medical advances-new drugs, biological devices, and surgical procedures-are developed, brought to market, evaluated, and adopted into health care. Cost-effective delivery of evidence-based health care is the sine qua non of American medicine in the twenty-first century. Health care decision makers, providers, payers, policymakers, and consumers all need vital information about the risks, benefits, and costs of new technologies in order to make informed decisions about which ones to adopt and how to use them. Alan B. Cohen and Ruth S. Hanft explore the evolving field of medical technology evaluation (MTE), as well as the current controversies surrounding the evaluation and diffusion of medical technologies, including the methods employed in their assessment and the policies that govern their adoption and use. The book opens with an introduction that provides basic definitions and the history of technological change in American medicine, and a second chapter that explores critical questions regarding medical technology in health care. Part I discusses biomedical innovation, the development and diffusion of medical technology, and the adoption and use of technology by hospitals, physicians, and other health care organizations and professions under changing health care market conditions. Part II examines the methods of MTE-including randomized controlled trials, meta-analyses, economic evaluation methods (such as cost-benefit, cost-effectiveness, and cost-utility analyses), and clinical decision analysis. Part III focuses on key public policy issues and concerns that affect the organization, financing, and delivery of health care and that relate importantly to medical technology, including safety, efficacy, quality, cost, access, equity, social, ethical, legal, and evaluation concerns. All three parts of the book provide a historical perspective on the relevant issues, methods, and policy concerns and contain examples of technologies whose development, adoption, evaluation, and use have contributed to our understanding of the field. This book will be invaluable in making MTE more accessible to individuals who are directly involved in the evaluation process and those who are touched by it in their professional lives-policymakers, clinicians, managers, and researchers.

Health Care After the COVID-19 Pandemic and the Influence of Telemedicine

State-related actions on compounding pharmacy

Patient Safety: Grantmakers Join The Effort To Reduce Medical Errors

Sidney Garfield—A Personal Recollection

Communication: Communication best practices (e.g., teaching goals of care conversations/

Moving Forward: Lessons Learned From the COVID-19 Pandemic.

Progressivity and horizontal equity in health care finance and delivery: What about Africa?

Implementation of a care bundle improves PBC management

SUMMARY Health care delivery in hospitals and clinics promotes an interdisciplinary team approach. This article presents the use of The Discipline though the involvements of the chaplain as part of the Infectious Disease team as together they addressed the inherent spirituality of one HIV/AIDS patient. This narrative recounts the unfolding events of the patient's life and describes the use of The Discipline during a very difficult time period for the patient and the staff. The experience can serve as a model for other health care teams who must manage difficult, deteriorating patients.

The Affordable Care Act (ACA) has reformed US health care delivery through insurance coverage expansion, experiments in payment design, and funding for patient-centered clinical and health care delivery research. The impact on cancer care specifically has been far reaching, with new ACA-related programs that encourage coordinated, patient-centered, cost-effective care. Insurance expansions through private exchanges and Medicaid, along with preexisting condition clauses, have helped more than 20 million Americans gain health care coverage. Accountable care organizations, oncology patient-centered medical homes, and the Oncology Care Model-all implemented through the Center for Medicare & Medicaid Innovation-have initiated an accelerating shift toward value-based cancer care. Concurrently, evidence for better cancer outcomes and improved quality of cancer care is starting to accrue in the wake of ACA implementation.